Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020
Stock Information for Capricor Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.